Both in Pharmaceuticals
AN2 Therapeutics vs PepGen
Over the past year ANTX returned +268.3% and PEPG returned −49.4%; their daily moves had a correlation of 0.03.
ANTX +268.3% PEPG −49.4%Growth of $1, one year, split-adjusted
| Metric | ANTX | PEPG |
|---|---|---|
| Price | $4.53 | $2.36 |
| Market cap | $170.9M | $163.5M |
| Today | −3.41% | −2.07% |
| 1 month | −19.4% | +6.8% |
| 6 months | −3.2% | +34.9% |
| Year to date | +297.4% | −63.7% |
| 1 year | +248.5% | −47.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $78.4M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 74.5% | 76.4% |
| Short % of float | 10.0% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).